GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicell Inc (MEX:OMCL) » Definitions » Cyclically Adjusted PS Ratio

Omnicell (MEX:OMCL) Cyclically Adjusted PS Ratio : 1.22 (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Omnicell Cyclically Adjusted PS Ratio?

As of today (2024-06-23), Omnicell's current share price is MXN3756.00. Omnicell's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was MXN3,080.10. Omnicell's Cyclically Adjusted PS Ratio for today is 1.22.

The historical rank and industry rank for Omnicell's Cyclically Adjusted PS Ratio or its related term are showing as below:

MEX:OMCL' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.13   Med: 4   Max: 10.2
Current: 1.14

During the past years, Omnicell's highest Cyclically Adjusted PS Ratio was 10.20. The lowest was 1.13. And the median was 4.00.

MEX:OMCL's Cyclically Adjusted PS Ratio is ranked better than
50.14% of 345 companies
in the Healthcare Providers & Services industry
Industry Median: 1.18 vs MEX:OMCL: 1.14

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Omnicell's adjusted revenue per share data for the three months ended in Mar. 2024 was MXN89.329. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is MXN3,080.10 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Omnicell Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Omnicell's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicell Cyclically Adjusted PS Ratio Chart

Omnicell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.62 7.50 9.67 2.34 1.61

Omnicell Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.64 3.24 1.94 1.61 1.22

Competitive Comparison of Omnicell's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, Omnicell's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicell's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Omnicell's Cyclically Adjusted PS Ratio falls into.



Omnicell Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Omnicell's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3756.00/3080.1
=1.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omnicell's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Omnicell's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=89.329/131.7762*131.7762
=89.329

Current CPI (Mar. 2024) = 131.7762.

Omnicell Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 37.208 100.560 48.758
201409 41.027 100.428 53.834
201412 48.932 99.070 65.086
201503 47.998 99.621 63.491
201506 47.790 100.684 62.548
201509 57.799 100.392 75.868
201512 61.794 99.792 81.599
201603 82.363 100.470 108.027
201606 88.856 101.688 115.147
201609 92.163 101.861 119.230
201612 96.688 101.863 125.082
201703 75.926 102.862 97.268
201706 85.288 103.349 108.747
201709 86.960 104.136 110.042
201712 89.585 104.011 113.499
201803 83.589 105.290 104.617
201806 92.683 106.317 114.878
201809 93.510 106.507 115.696
201812 100.125 105.998 124.475
201903 92.912 107.251 114.159
201906 97.247 108.070 118.580
201909 104.921 108.329 127.630
201912 107.938 108.420 131.190
202003 123.465 108.902 149.399
202006 108.012 108.767 130.861
202009 108.050 109.815 129.658
202012 112.613 109.897 135.033
202103 111.026 111.754 130.917
202106 115.254 114.631 132.492
202109 126.076 115.734 143.551
202112 127.136 117.630 142.426
202203 132.480 121.301 143.921
202206 144.116 125.017 151.908
202209 152.801 125.227 160.793
202212 129.889 125.222 136.688
202303 116.706 127.348 120.764
202306 112.719 128.729 115.387
202309 114.100 129.860 115.784
202312 96.572 129.419 98.331
202403 89.329 131.776 89.329

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Omnicell  (MEX:OMCL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Omnicell Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Omnicell's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicell (MEX:OMCL) Business Description

Traded in Other Exchanges
Address
2625 Augustine Drive, Suite 301, Santa Clara, CA, USA, 95054
Omnicell Inc provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.